ArticleFrontiers in pharmacology2024

Concomitant inhibition of PI3K/mTOR signaling pathways boosts antiproliferative effects of lanreotide in bronchopulmonary neuroendocrine tumor cells.

Claus von Hessert-Vaudoncourt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.